Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000153604 | SCV000203147 | likely benign | not specified | 2015-05-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001704115 | SCV000241846 | likely benign | not provided | 2021-01-29 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000467253 | SCV000431212 | likely benign | Pitt-Hopkins-like syndrome 2 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Invitae | RCV000467253 | SCV000562380 | likely benign | Pitt-Hopkins-like syndrome 2 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316971 | SCV000850190 | uncertain significance | Inborn genetic diseases | 2018-08-14 | criteria provided, single submitter | clinical testing | The p.D273G variant (also known as c.818A>G), located in coding exon 2 of the NRXN1 gene, results from an A to G substitution at nucleotide position 818. The aspartic acid at codon 273 is replaced by glycine, an amino acid with similar properties. Based on data from gnomAD, the G allele has an overall frequency of approximately 0.05% (141/264288) total alleles studied. The highest observed frequency was 0.56% (129/23136) of African alleles. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV000467253 | SCV001519733 | uncertain significance | Pitt-Hopkins-like syndrome 2 | 2019-02-01 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |